A pilot study of hepatic artery floxuridine combined with systemic 5‐fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases Academic Article Article uri icon

Overview

MeSH Major

  • Acquired Immunodeficiency Syndrome

abstract

  • Systemic 5-FU and LV can be combined safely with intraarterial FUDR without loss of efficacy or increased biliary toxicity. Eight patients treated with this regimen as adjuvant therapy after liver metastasis resection were alive and disease-free after a median follow-up of 23 months.

publication date

  • January 1993

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(19930315)71:6<1964::AID-CNCR2820710607>3.0.CO;2-T

PubMed ID

  • 8443746

Additional Document Info

start page

  • 1964

end page

  • 71

volume

  • 71

number

  • 6